Evidence map›Paper›PMID 17198872›Full record

ArticleExperimental hematology2007

Altered regulation of beta-like globin genes by a redesigned erythroid transcription factor.

Deepa Manwani, Mariann Galdass, James J Bieker

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neutralizing the function of a β-globin-associated cis-regulatory DNA element using an artificial zinc finger DNA-binding domain.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  5. Article
  6. Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kruppel-like factor.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Deepa ManwaniDepartment of Molecular, Cell and Developmental Biology, Mount Sinai School of Medicine, New York, NY 10029, USA. deepa.manwani@mssn.edu
Mariann Galdass
James J Bieker
Icahn School of Medicine at Mount Sinai · US

Funding

TRANSGENIC MODLES AND GENETIC MODIFIERS OF SICKLE CELL DISEASEP60HL028381 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PIOMELLI, SERGIO S · 1985 to 2002
$6.5M
GENE KNOCKOUT/TRANSGENIC ANIMAL SHARED RESOURCER24CA088302 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI KELLEY, KEVIN A · 2001 to 2005
$767k
USE OF MODIFIED EKLF FOR GAMMA GLOBIN AUGMENTATIONK08DK002871 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MANWANI, DEEPA G · 2000 to 2004
$631k
NCI NIH HHS R24 CA088302NCI NIH HHS R24 CA88302NHLBI NIH HHS P60 HL28381NIDDK NIH HHS K08 DK002871
6 · The paper itself

Abstract

objectiveTargeted regulation of beta-like globin genes was studied using designer zinc finger transcription factors containing the DNA binding domain of the red cell specific transcription factor erythroid Kruppel-like factor (EKLF) fused to repression domains.

methodsGlobin gene expression was analyzed after introduction of the modified transcription factors into cell lines, embryonic stem cells and transgenic mice.

resultsAs would be predicted, when introduced transiently into cells these transcription factors were effective in repressing the adult beta-globin promoter CACCC element, which is the natural target for EKLF. In murine erythroleukemia cells repression of the adult beta-globin gene was accompanied by a reactivation of the endogenous embryonic betaH1-globin gene. Studies in differentiated embryonic stem cells and transgenic mice confirmed the reactivation of embryonic gene expression during development.

conclusionOur studies support a competition model for beta-globin gene expression and underscore the importance of EKLF in the embryonic/fetal-to-adult globin switch. They also demonstrate the feasibility of designer zinc finger transcription factors in the study of transcriptional control mechanisms at the beta-globin locus and as potential gene therapy agents for sickle cell disease and related hemoglobinopathies.

Indexed as

AnimalsCell LineEmbryo, MammalianErythroid CellsGene Expression RegulationGenes, SwitchGlobinsKruppel-Like Transcription FactorsMiceMice, TransgenicProtein EngineeringRecombinant Fusion ProteinsRepressor ProteinsResponse ElementsStem CellsTransduction, GeneticGlobinsKruppel-Like Transcription FactorsRecombinant Fusion ProteinsRepressor Proteins

Identifiers

PMID17198872
PMCPMC1892846
OpenAlexW2027517308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.